Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
15.97
+1.30 (8.86%)
At close: Oct 2, 2025, 4:00 PM EDT
15.86
-0.11 (-0.69%)
After-hours: Oct 2, 2025, 7:47 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $885.14 million as of October 2, 2025. Its market cap has increased by 155.03% in one year.
Market Cap
885.14M
Enterprise Value
840.28M
1-Year Change
155.03%
Ranking
Category
Stock Price
$15.97
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $885.14M, a decrease of -59.44%. That is a compound annual growth rate of -18.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 813.09M | 55.98% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | 2.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 733.27B |
| Johnson & Johnson | 448.19B |
| AbbVie | 418.29B |
| UnitedHealth Group | 315.27B |
| AstraZeneca | 259.87B |
| Novo Nordisk | 255.80B |
| Novartis AG | 252.22B |
| Abbott Laboratories | 228.82B |